| KAIROS-BIDCO-AB |
KAIROS-BIDCO-AB |
92%
|
the Company agreed to sell and Karo agreed to acquire |
| KARO-HEALTHCARE-AB |
KARO-HEALTHCARE-AB |
92%
|
the Company agreed to sell and Karo agreed to acquire |
| KKR-CO-INC |
KKR-CO-INC |
90%
|
an investment vehicle managed by an affiliate of KKR & Co., Inc. |
| CONRY-PLAINTIFFS |
CONRY-PLAINTIFFS |
80%
|
The Conry Action was brought by a proposed class of Store Brand infant formula purchasers (the “Conry Plaintiffs”). |
| P-L-DEVELOPMENT-LLC |
P-L-DEVELOPMENT-LLC |
80%
|
The PLD Action was brought by P&L Development, LLC. |
| BLRX |
BioLineRx Ltd. |
72%
|
Reciprocal relationship from BLRX graph: ction 404 is complicated and time-consuming. Furthermore, as our business continues to grow both domestically and internationally, our internal controls will … |
| GLMD |
Galmed Pharmaceuticals Ltd. |
72%
|
Reciprocal relationship from GLMD graph: cilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are seeking approval. … |
| JNJ |
Johnson & Johnson |
72%
|
eral courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (“ASD”) and attention-deficit/hyperactivity disorder (“ADHD”). … |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from JNJ grap… |
| PRTA |
Prothena Corporation plc |
72%
|
Reciprocal relationship from PRTA graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from PRTA graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from PRTA g… |
| SLGL |
Sol-Gel Technologies Ltd. |
72%
|
Reciprocal relationship from SLGL graph: in Mexico (with a term until 2029) and pending in the United States and Canada; and the second patent family granted in Europe (validated in France, Germany, … |
| SLGN |
Silgan Holdings Inc. |
72%
|
Reciprocal relationship from SLGN graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from SLGN graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from SLGN g… |
| STORE-BRAND-INFANT-FORMULA-PURCHASERS |
STORE-BRAND-INFANT-FORMULA-PURCHASERS |
70%
|
The Conry Action was brought by a proposed class of Store Brand infant formula purchasers (the “Conry Plaintiffs”). |
| CONRY-LITIGATION-PERRIGO-COMPANY |
CONRY-LITIGATION-PERRIGO-COMPANY |
62%
|
Item 1 Note 16 Phenylephrine In September 2023, the Food and Drug Administration’s (“FDA”) Advisory Committee on Nonprescription Drugs issued an advisory opinion calling into question the efficacy of… |
| CVS |
CVS Health Corporation |
62%
|
Reciprocal relationship from CVS graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from CVS graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from CVS grap… |
| CVS-PHARMACY-INC |
CVS-PHARMACY-INC |
62%
|
e been consolidated in the In re Generic Pharmaceuticals Pricing Antitrust Litigation multidistrict litigation (“MDL”) MDL No. 2724 (United States District Court for Eastern District of Pennsylvania)… |
| FITCH-RATINGS-INC |
FITCH-RATINGS-INC |
62%
|
. Credit Ratings Our credit ratings on March 28, 2026 were Ba3 (negative), B+ (stable), and BB (negative) by Moody's Investor Services ("Moody's"), S&P Global Ratings ("S&P"), and Fitch Ratings Inc. … |
| JOHNSON-CONSUMER-INC |
JOHNSON-CONSUMER-INC |
62%
|
eral courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (“ASD”) and attention-deficit/hyperactivity disorder (“ADHD”). … |
| KENVUE-BRANDS-LLC |
KENVUE-BRANDS-LLC |
62%
|
eral courts alleging that prenatal exposure to acetaminophen is purportedly associated with the development of autism spectrum disorder (“ASD”) and attention-deficit/hyperactivity disorder (“ADHD”). … |
| KR |
The Kroger Co. |
62%
|
Reciprocal relationship from KR graph: Reciprocal relationship from PRGO graph: e been consolidated in the In re Generic Pharmaceuticals Pricing Antitrust Litigation multidistrict litigation (“MDL”) … |
| KROGER-CO-CIGNA-CORP |
KROGER-CO-CIGNA-CORP |
62%
|
e been consolidated in the In re Generic Pharmaceuticals Pricing Antitrust Litigation multidistrict litigation (“MDL”) MDL No. 2724 (United States District Court for Eastern District of Pennsylvania)… |
| L-PERRIGO-COMPANY |
L-PERRIGO-COMPANY |
62%
|
Item 1 Note 16 Phenylephrine In September 2023, the Food and Drug Administration’s (“FDA”) Advisory Committee on Nonprescription Drugs issued an advisory opinion calling into question the efficacy of… |
| PBM-NUTRITIONALS-LLC |
PBM-NUTRITIONALS-LLC |
62%
|
Item 1 Note 16 Phenylephrine In September 2023, the Food and Drug Administration’s (“FDA”) Advisory Committee on Nonprescription Drugs issued an advisory opinion calling into question the efficacy of… |
